Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TUPKRP Combined With Endocrine Therapy for Advanced Prostate Cancer With Severe LUTS
NCT03701659Unknown
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Dec 2018
- Primary completion
- Nov 2023
01
Overview
Open-label trial (2 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoints: Prostate Specific Antigen at 3 months, Maximum flow rate at 3 months and 8 more. Status: unknown.
Beyond the preview
Go deeper on NCT03701659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03701659.